Cethromycin - Wikipedia, the free encyclopedia
Cethromycin (initially known as ABT-773 [1] [2]) is a ketolide antibiotic undergoing research for the treatment of community acquired pneumonia (CAP) [1] [3] [4] [5] and for the ...
Ketolide - Wikipedia, the free encyclopedia
The only ketolide on the market at this moment is telithromycin, which is sold under the brand name of Ketek. Another promising ketolide is cethromycin.
BioWorld Today
"So there's a great opportunity for cethromycin to become a front-line" treatment, Flavin added. In Phase III studies, once-daily oral cethromycin proved noninferior to the current ...
File:Cethromycin.svg - Wikimedia Commons
The following 2 pages on Wikimedia Commons link to this file. Some pages on other Wikimedia projects may also link to it. User:NEUROtiker/gallery/archive3
Noninferiority Trials
Testimony of James Floyd, M.D., Public Citizen June 2, 2009 Meeting of Anti-Infective Drugs Advisory Committee Cethromycin for the Treatment of Community-Acquired Bacterial ...
Advanced Life Sciences submits NDA for cethromycin in mild-to-moderate ...
Advanced Life Sciences Holdings, Inc. has announced the submission of a new drug application (NDA) for cethromycin in mild-to-moderate community acquired pneumonia (CAP).
Efficacy of Cethromycin, a New Ketolide, against Streptococcus ...
Cethromycin is a ketolide with in vitro activity against macrolide-sensitive and -resistant strains of Streptococcus pneumoniae. We compared its in vivo efficacy to erythromycin in ...
Therapeutics Daily
CHICAGO, May 2 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. today announced that its novel respiratory antibiotic, Cethromycin, was shown to be effective in ...
Defense Dept. exercises cethromycin option - UPI.com
The U.S. Defense Department has exercised a contract option with Advanced Life Sciences Holdings Inc. to continue development of a biological defense therapy.
Cethromycin for the Treatment of Community-Acquired Bacterial ...
Cethromycin for the Treatment of Community-Acquired Bacterial Pneumonia FDA Briefing Document for Anti-Infective Drugs Advisory Committee Meeting June 2, 2009
Investors Anticipating FDA Approval of Cethromycin :: The OTC Investor ...
Advanced Life Sciences Holdings, Inc. [[ADLS.OB]] may not be the most well known company in the biopharmaceutical space, but the stock’s rapid price movement is catching the ...
